Tag Archives: ACHV

Achieve Life Sciences (ACHV) Scheduled to Post Quarterly Earnings on Thursday

Achieve Life Sciences (NASDAQ:ACHV – Get Rating) will be announcing its earnings results after the market closes on Thursday, August 11th. Analysts expect the company to announce earnings of ($0.79) per share for the quarter. Investors interested in listening to the company’s conference call can do so using this link. Achieve Life Sciences (NASDAQ:ACHV – Get Rating) last released its quarterly earnings data on Thursday, May 12th. The biopharmaceutical company reported ($0.80) earnings per share for the quarter, beating the consensus estimate of ($0.82) by $0.02. During […]

Read more

Achieve Life Sciences Announce – GuruFocus.com

SEATTLE and VANCOUVER, British Columbia, June 29, 2022 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc. ( ACHV), a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced it has initiated screening of subjects for the ORCA-V1 Phase 2 clinical trial. ORCA-V1 will evaluate the efficacy and safety of 3mg cytisinicline dosed 3 times daily compared to placebo in approximately 150 adult e-cigarette users at 5 clinical trial locations in the United States. Participants will be randomized […]

Read more